Navigation Links
Bioprosthesis in Medical News

ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States

MINNEAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f(R) Aortic Bioprosthesis were completed by Dr. Allan Stewar...

ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Feb. 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the Australian Therapeutic Goods Administration (TGA) has granted approval for commercialization of the A...

ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received U.S. Food and Drug Administration (FDA) approval for the ATS 3f(R) Aortic Bioprosthesis. (Lo...

ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis

MINNEAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- ATS Medical Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that a total of 47 patients have now undergone aortic valve replacement with its sutureless ATS 3f Enable(TM) A...

ATS Medical Announces Second Quarter 2009 Results

...erlin presented five-year single center follow-up data on the ATS 3F Aortic bioprosthesis highlighting the valve's excellent safety and performance profile. Dr... U.K. presented five-year hemodynamic performance data on the ATS 3F Aortic bioprosthesis as assessed by valve energy loss and pressure gradient. Dr. Jin's findings...

ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America

...Five Year Hemodynamic Performance of ATS 3f Aortic bioprosthesis Assessed By Valve Energy Loss and Pressure Gradien...inical Experience with the ATS 3f Stentless Aortic bioprosthesis - Five Years Follow Up," Joerg Linneweber, M.D., K...ng the ATS exhibition will be the ATS 3f(R) Aortic bioprosthesis which is designed to replace the patient's disease...

ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting

...of the ATS exhibition will be the ATS 3f(R) Aortic bioprosthesis which is designed to replace the patient's diseased valve. The ATS 3f Aortic bioprosthesis is a revolutionary next generation stentless peric.... By restoring this continuity, the ATS 3f Aortic bioprosthesis is the only aortic valve that preserves the sinuse...

ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting

...volutionary next generation stentless pericardical aortic tissue valve that is unlike any other. Post-approval commercialization of the ATS 3f Aortic bioprosthesis continues with the valve's unique design and compelling clinical benefits generating enthusiasm and product demand among U.S. surgeons. The ATS...

ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting

...ic Bioprosthesis incorporates the ATS 3f(R) Aortic bioprosthesis on a Nitinol self-expanding frame which eliminates...ht several products including the ATS 3f(R) Aortic bioprosthesis and the new ATS CryoMaze(TM) Clamp. Based on the p...that 'Form Follows Function', the ATS 3f(R) Aortic bioprosthesis is a revolutionary stentless pericardial aortic ti...

ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations

... surgical procedures for the treatment of atrial fibrillation that can improve efficacy while reducing the risk profile. The ATS 3f Enable(R) Aortic bioprosthesis is currently in clinical trials in Europe and is designed to eliminate the traditional suturing now required when replacing a patient's diseased or de...
Bioprosthesis in Medical Products

Mosaic Aortic Bioprosthesis with CINCH Advanced Implant System

Description: Mosaic, the third generation tissue valve from Medtronic, is the only third generation stented tissue valve available. The Mosaic valve builds upon three decades of tissue valve experience and is an excellent choice for patients who require aortic or mitral valve replacement with a tissue valve. Fo...
Company:Medtronic Inc.

Hancock® Standard Mitral Bioprosthesis

Description: The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for patients requiring mitral valve replacement--particularly elderly patients and those with coronary ...
Company:Medtronic Inc.

Hancock II Aortic Bioprostheses with CINCH Advanced Implant System

Description:... The Hancock II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.

Hancock® II Aortic Bioprostheses

Description:... The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.

Hancock® II Mitral Bioprostheses

Description:... The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.
Bioprosthesis in Biological Technology

ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing t...

ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis

Follows Canadian regulatory approval of the ATS 3f Valve MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first North American commercial implant ...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

...S's broad product offering is the ATS 3f(R) Aortic bioprosthesis designed to replace the patient's diseased valve. The ATS 3f Aortic bioprosthesis is a revolutionary next generation stentless peric.... By restoring this continuity, the ATS 3f Aortic bioprosthesis is the only aortic valve that preserves the sinuse...

ATS Medical Announces Record Quarterly Revenue and Gross Profit

...he ATS 3f Aortic Bioprosthesis. The Company submitted answers to the FDA in March 2008. Management continues to expect that the ATS 3f Aortic bioprosthesis will be approved in the second half of 2008. -- ATS 3f Enable(TM) Aortic Bioprosthesis: Enrollment continues to progress with excellent cli...
Other Tags
(Date:6/19/2013)... STRATFORD, Conn (PRWEB) June 20, 2013 A man ... same man he used to be. In his debut book titled ... a war veteran who immerses himself back home, looking for the ... When Gabriel De Los Angeles, former marine from the Vietnam War, ... to take the edge off his PTSD. Wings, a wealthy acquaintance ...
(Date:6/19/2013)... Across the globe billions of people live ... the medical advances that benefit developed western society. ... and the necessary aid to help curb the conditions ... Outlook with Ben Kingsley is partnering with some ... these people live and highlight the invaluable resources being ...
(Date:6/19/2013)... 2013 HASCO Medical, Inc. (OTCBB: ... intent to purchase privately held Auto Mobility Sales, ... wheelchair accessible vehicle sales, service and rentals in ... Inc compliments and expands HASCO's strategy of becoming ... dealers . The acquisition is subject to customary ...
(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...
(Date:6/19/2013)... Citi Bike has come to New York City in ... to know for sure how many patients will choose to take ... the option. In fact, he’s happy about anything that might ... it more convenient for them to visit his office at 133 ... Alternative Medicine at Back and Body Medical and an experienced ...
Breaking Medicine News(10 mins):Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3
(Date:6/19/2013)... Tanzania is playing a vital role in the survival ... response to climate and environmental changes, according to new ... on savannah birds from the Tanzanian Bird Atlas project ... decades - the researchers found that they are using ... areas further west where dry seasons are getting longer, ...
(Date:6/19/2013)... Science Consortium (PISC) is extremely disappointed that the ... upheld a decision that requires Dow Benelux B.V.to ... The study will use approximately 1160 animals and ... the substance dipropylene glycol methyl ether acetate (DPMA) ... Regulation on the Registration, Evaluation, Authorisation and Restriction ...
(Date:6/19/2013)... A team of researchers at the University of ... outer coating of HIV, that could be potential ... avoid generating resistance. These new agents are quite ... The research was published in the June 2013 ... Chemotherapy . , The first of many probable ...
Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2HIV-derived antibacterial shows promise against drug-resistant bacteria 2
Other Contents